Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer drugs
clinical trials
life sciences
national blog main
san francisco blog main
cancer
national top stories
san francisco top stories
deals
europe blog main
fda
investing
ipo
revolution medicines
san francisco
sanofi
the column group
third rock ventures
warp drive bio
acute myeloid leukemia
alx oncology
amgen
autoimmune diseases
berkeley lights
biotech ipos
black diamond therapeutics
bladder cancer
blueprint medicines
cancer immunotherapy
cd47
chronic kidney disease
cobimetinib
colorectal cancer
deciphera pharmaceuticals
deerfield healthcare technology acquisitions
deerfield management company
eli lilly
What
ipo
4
×
research
4
×
cancer
medicines
biotech
companies
drug
new
proteins
revolution
targets
arrival
black
cancer’s
clinic
days
despite
diamond
disease
eluded
family
frontiers
hardest
hasn’t
hit
hopes
hottest
hunters
industry
ipos
known
lead
leading
life
lines
maps
market
molecular
momentum
nears
Language
unset
Current search:
ipo
×
research
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
